These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30321513)

  • 21. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
    Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
    J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in tear protein profile in patients with conjunctivochalasis.
    Acera A; Suárez T; Rodríguez-Agirretxe I; Vecino E; Durán JA
    Cornea; 2011 Jan; 30(1):42-9. PubMed ID: 20861728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tears and ocular surface disorders: Usefulness of biomarkers.
    Di Zazzo A; Micera A; De Piano M; Cortes M; Bonini S
    J Cell Physiol; 2019 Jul; 234(7):9982-9993. PubMed ID: 30515814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Tear Fluid Proteomics-A Novel Tool in Glaucoma Research.
    Nättinen J; Aapola U; Nukareddy P; Uusitalo H
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's the situation with ocular inflammation? A cross-seasonal investigation of proteomic changes in ocular allergy sufferers' tears in Victoria, Australia.
    Aydin E; Nie S; Azizoglu S; Chong L; Gokhale M; Suphioglu C
    Front Immunol; 2024; 15():1386344. PubMed ID: 38855108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases.
    Pieragostino D; D'Alessandro M; di Ioia M; Di Ilio C; Sacchetta P; Del Boccio P
    Proteomics Clin Appl; 2015 Feb; 9(1-2):169-86. PubMed ID: 25488355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication.
    Wong TT; Zhou L; Li J; Tong L; Zhao SZ; Li XR; Yu SJ; Koh SK; Beuerman RW
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7385-91. PubMed ID: 21697136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevation of human alpha-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium.
    Zhou L; Beuerman RW; Ang LP; Chan CM; Li SF; Chew FT; Tan DT
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2077-86. PubMed ID: 19168894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear film proteome in age-related macular degeneration.
    Winiarczyk M; Kaarniranta K; Winiarczyk S; Adaszek Ł; Winiarczyk D; Mackiewicz J
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1127-1139. PubMed ID: 29696386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-depth analysis of the human tear proteome.
    Zhou L; Zhao SZ; Koh SK; Chen L; Vaz C; Tanavde V; Li XR; Beuerman RW
    J Proteomics; 2012 Jul; 75(13):3877-85. PubMed ID: 22634083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction.
    Soria J; Durán JA; Etxebarria J; Merayo J; González N; Reigada R; García I; Acera A; Suárez T
    J Proteomics; 2013 Jan; 78():94-112. PubMed ID: 23201116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen's disease: a tear proteomic study.
    Mukhopadhyay S; Sen S; Datta H
    Br J Ophthalmol; 2015 Jan; 99(1):108-12. PubMed ID: 25138758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-translation modification of proteins in tears.
    You J; Fitzgerald A; Cozzi PJ; Zhao Z; Graham P; Russell PJ; Walsh BJ; Willcox M; Zhong L; Wasinger V; Li Y
    Electrophoresis; 2010 Jun; 31(11):1853-61. PubMed ID: 20506419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of human tear proteome using multiple proteomic analysis techniques.
    Li N; Wang N; Zheng J; Liu XM; Lever OW; Erickson PM; Li L
    J Proteome Res; 2005; 4(6):2052-61. PubMed ID: 16335950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered tear composition in smokers and patients with graves ophthalmopathy.
    Baker GR; Morton M; Rajapaska RS; Bullock M; Gullu S; Mazzi B; Ludgate M
    Arch Ophthalmol; 2006 Oct; 124(10):1451-6. PubMed ID: 17030713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance P in Flush Tears and Schirmer Strips of Healthy Participants.
    Markoulli M; Gokhale M; You J
    Optom Vis Sci; 2017 Apr; 94(4):527-533. PubMed ID: 28033160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of tears following acupuncture treatment for menopausal dry eye disease by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry.
    Liu Q; Liu J; Ren C; Cai W; Wei Q; Song Y; Yu J
    Int J Nanomedicine; 2017; 12():1663-1671. PubMed ID: 28280333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of human tear proteins using high-resolution mass spectrometry.
    Zhou L; Beuerman RW; Foo Y; Liu S; Ang LP; Tan DT
    Ann Acad Med Singap; 2006 Jun; 35(6):400-7. PubMed ID: 16865190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tear analysis in ocular surface diseases.
    Zhou L; Beuerman RW
    Prog Retin Eye Res; 2012 Nov; 31(6):527-50. PubMed ID: 22732126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Graves' ophthalmopathy patients' tear protein spectrum.
    Jiang LH; Wei RL
    Chin Med J (Engl); 2013 Dec; 126(23):4493-8. PubMed ID: 24286413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.